Rating History for Prometheus Biosciences Inc (RXDX) by Wells Fargo
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/18/2023 | Chris M. Carey | Downgrade | Equal Weight (Overweight) |
200.00 (N/A) |
114.01 (199.92) |
75.35% | Details |
 |
|||||||
|
|||||||
|
|||||||
